LENSAR, Inc. (LNSR)
NASDAQ: LNSR · Real-Time Price · USD
5.09
-0.17 (-3.23%)
At close: Apr 24, 2026, 4:00 PM EDT
5.10
+0.01 (0.20%)
After-hours: Apr 24, 2026, 5:31 PM EDT
LENSAR Revenue
In the year 2025, LENSAR had annual revenue of $58.44M with 9.24% growth. LENSAR had revenue of $16.03M in the quarter ending December 31, 2025, a decrease of -4.22%.
Revenue (ttm)
$58.44M
Revenue Growth
+9.24%
P/S Ratio
1.05
Revenue / Employee
$389,567
Employees
150
Market Cap
61.57M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 58.44M | 4.94M | 9.24% |
| Dec 31, 2024 | 53.49M | 11.33M | 26.87% |
| Dec 31, 2023 | 42.16M | 6.81M | 19.25% |
| Dec 31, 2022 | 35.36M | 899.00K | 2.61% |
| Dec 31, 2021 | 34.46M | 8.08M | 30.62% |
| Dec 31, 2020 | 26.38M | -4.15M | -13.58% |
| Dec 31, 2019 | 30.53M | 6.14M | 25.18% |
| Dec 31, 2018 | 24.39M | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Accuray | 436.97M |
| Xtant Medical Holdings | 133.93M |
| Pulmonx | 90.50M |
| Baird Medical Investment Holdings | 31.86M |
| Sensus Healthcare | 27.48M |
| Spectral AI | 19.65M |
| InspireMD | 8.98M |
| Picard Medical | 4.94M |
LNSR News
- 25 days ago - LENSAR® Reports Fourth Quarter and Full Year 2025 Results and Provides Business Update - GlobeNewsWire
- 5 weeks ago - LENSAR Stock Plunges—Alcon Scraps Merger After Prolonged Regulatory Review - Benzinga
- 5 weeks ago - LENSAR® Announces Termination of Merger Agreement with Alcon Research, LLC - GlobeNewsWire
- 2 months ago - LENSAR® Provides Update on Pending Acquisition by Alcon - GlobeNewsWire
- 6 months ago - LENSAR® Reports Third Quarter 2025 Results and Provides Business Update - GlobeNewsWire
- 8 months ago - LENSAR Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewsWire
- 9 months ago - LENSAR Reports Second Quarter 2025 Results and Provides Business Update - GlobeNewsWire
- 11 months ago - LENSAR INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of LENSAR, Inc. - LNSR - Business Wire